CBOA
ABBV icon

Commonwealth Bank of Australia’s AbbVie ABBV Stock Holding History

Commonwealth Bank of Australia’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-136,156
Closed -$9.89M – 6
2019
Q2 		$9.89M Sell
136,156
-35,297
-21% -$2.77M 0.1% 143
2019
Q1 		$13.8M Buy
171,453
+45,144
+36% +$3.69M 0.13% 108
2018
Q4 		$11.6M Buy
126,309
+14,214
+13% +$1.25M 0.13% 112
2018
Q3 		$10.6M Buy
112,095
+5,500
+5% +$522K 0.1% 135
2018
Q2 		$9.87M Sell
106,595
-275
-0.3% -$26.9K 0.1% 141
2018
Q1 		$10.1M Sell
106,870
-16,041
-13% -$1.76M 0.11% 134
2017
Q4 		$11.9M Sell
122,911
-4,839
-4% -$456K 0.12% 133
2017
Q3 		$11.3M Buy
127,750
+5,726
+5% +$436K 0.11% 139
2017
Q2 		$8.85M Buy
122,024
+6,417
+6% +$431K 0.09% 156
2017
Q1 		$7.53M Buy
115,607
+10,885
+10% +$684K 0.08% 158
2016
Q4 		$6.56M Buy
104,722
+13,994
+15% +$854K 0.08% 168
2016
Q3 		$5.72M Buy
90,728
+1,700
+2% +$110K 0.07% 166
2016
Q2 		$5.51M Buy
89,028
+2,898
+3% +$177K 0.06% 173
2016
Q1 		$4.92M Buy
86,130
+5,309
+7% +$296K 0.06% 193
2015
Q4 		$4.79M Sell
80,821
-10,594
-12% -$610K 0.06% 189
2015
Q3 		$4.97M Buy
91,415
+1,380
+2% +$89.8K 0.06% 188
2015
Q2 		$6.05M Buy
90,035
+4,492
+5% +$293K 0.08% 152
2015
Q1 		$5.01M Buy
85,543
+4,400
+5% +$266K 0.07% 170
2014
Q4 		$5.31M Sell
81,143
-20,479
-20% -$1.29M 0.08% 157
2014
Q3 		$5.87M Buy
101,622
+6,400
+7% +$355K 0.08% 168
2014
Q2 		$5.37M Sell
95,222
-195,503
-67% -$10.3M 0.07% 169
2014
Q1 		$14.9M Buy
290,725
+13,852
+5% +$700K 0.1% 214
2013
Q4 		$14.6M Buy
276,873
+58,883
+27% +$2.89M 0.1% 208
2013
Q3 		$9.75M Sell
217,990
-922
-0.4% -$40.9K 0.07% 255
2013
Q2 		$9.05M Buy
+218,912
New +$9.57M 0.07% 256

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Commonwealth Bank of Australia's ABBV Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 136,156 shares — an estimated $9.89M sold.

Commonwealth Bank of Australia first reported a position in ABBV in Q2 2013 and held it in 25 quarters. The position peaked at $14.9M in Q1 2014. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 136,156 AbbVie shares in Q3 2019, an estimated $9.89M.
  • Commonwealth Bank of Australia first reported a position in AbbVie in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's AbbVie position peaked at $14.9M in Q1 2014.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.